av/natco-pharma--big.svg

NSE:NATCOPHARM

NATCO Pharma Limited

  • Stock

INR

Last Close

1,011.15

03/05 09:59

Market Cap

157.62B

Beta: 0.42

Volume Today

930.31K

Avg: 330.36K

PE Ratio

13.65

PFCF: -

Dividend Yield

1.11%

Payout:0%

Mar '14
Mar '15
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
average inventory
1.64B
-
2.01B
22.61%
2.89B
43.92%
3.53B
22.33%
3.94B
11.49%
4.84B
22.88%
5.43B
12.36%
6.78B
24.77%
7.80B
15.04%
7.52B
3.54%
average payables
1.06B
-
1.18B
10.87%
639.28M
45.61%
22.78M
96.44%
34M
49.27%
1.11B
3,161.76%
2.36B
112.98%
2.01B
14.99%
1.54B
23.31%
2.13B
38.18%
average receivables
1.46B
-
1.81B
24.10%
2.92B
61.96%
4.49B
53.38%
6.22B
38.65%
7.01B
12.73%
3.43B
51.11%
2.35B
31.36%
5.71B
142.58%
7.69B
34.66%
book value per share
45.44
-
51.09
12.42%
76.17
49.09%
94.66
24.28%
173.26
83.03%
189.41
9.32%
207.41
9.50%
226.26
9.09%
233.75
3.31%
266.96
14.21%
capex per share
-6.91
-
-7.20
4.18%
-9.23
28.26%
-16.04
73.76%
-23.93
49.16%
-25.06
4.74%
-19.71
21.36%
-13.98
29.09%
-13.31
4.80%
-11.26
15.36%
capex to depreciation
-3.63
-
-2.52
30.43%
-3.09
22.46%
-5.14
66.35%
-6.41
24.75%
-5.70
11.07%
-3.59
36.96%
-2.18
39.39%
-1.70
21.85%
-1.26
26.25%
capex to operating cash flow
-0.77
-
-1.29
67.89%
-1.54
19.49%
-0.81
47.42%
-0.92
13.23%
-0.69
24.57%
-0.86
24.48%
-0.85
0.84%
-5.22
512.55%
-0.24
95.36%
capex to revenue
-0.15
-
-0.15
3.58%
-0.14
3.93%
-0.14
2.06%
-0.20
43.59%
-0.22
13.82%
-0.19
15.17%
-0.15
20.71%
-0.13
15.41%
-0.08
40.39%
cash per share
0.66
-
0.76
15.01%
3.82
403.03%
7.87
106.41%
47.73
506.09%
57.41
20.29%
49.61
13.60%
44.48
10.34%
41.66
6.33%
63.65
52.79%
days of inventory on hand
239.72
-
283.50
18.26%
331.72
17.01%
183.50
44.68%
314.44
71.35%
418.02
32.94%
399.35
4.47%
479.26
20.01%
408.11
14.85%
432.26
5.92%
days payables outstanding
145.30
-
161.47
11.13%
2.37
98.53%
1.05
55.66%
3.44
227.29%
171.48
4,880.84%
182.79
6.60%
87.78
51.98%
86.66
1.28%
153.49
77.13%
days sales outstanding
72.97
-
95.89
31.41%
120.02
25.16%
94.35
21.39%
121.28
28.54%
121.37
0.08%
101.62
-
128.57
26.52%
116.80
9.15%
debt to assets
0.20
-
0.23
12.07%
0.06
72.74%
0.10
54.99%
0.05
51.24%
0.09
92.56%
0.07
20.02%
0.06
17.48%
0.08
42.72%
0.03
65.15%
debt to equity
0.33
-
0.37
11.30%
0.09
76.59%
0.13
55.04%
0.06
58.04%
0.11
96.39%
0.09
21.16%
0.07
21.09%
0.10
47.10%
0.03
66.24%
dividend yield
0.01
-
0.00
62.37%
0.00
29.86%
0.01
156.97%
0.01
39.26%
0.01
19.75%
0.02
56.92%
0.01
54.65%
0.01
21.31%
0.01
63.80%
earnings yield
0.04
-
0.02
52.14%
0.02
14.46%
0.03
48.91%
0.05
54.95%
0.06
21.60%
0.05
19.06%
0.03
41.48%
0.01
57.96%
0.07
464.26%
enterprise value
27.82B
-
72.86B
161.86%
71.03B
2.51%
149.93B
111.09%
138.29B
7.76%
107.69B
22.13%
95.07B
11.72%
152.96B
60.89%
141.13B
7.73%
103.20B
26.88%
enterprise value over ebitda
14.36
-
32.44
125.84%
24.62
24.12%
20.79
15.53%
14.26
31.40%
11.83
17.06%
14.08
19.00%
22.33
58.63%
42.26
89.23%
9.92
76.52%
ev to operating cash flow
19.32
-
78.62
307.02%
69.38
11.76%
43.36
37.50%
29.83
31.20%
16.10
46.02%
22.78
41.49%
51.19
124.70%
303.51
492.89%
12.15
96.00%
ev to sales
3.81
-
8.90
133.75%
6.31
29.05%
7.35
16.40%
6.41
12.76%
5.22
18.54%
5.04
3.58%
9.05
79.69%
7.41
18.13%
3.81
48.55%
free cash flow per share
2.11
-
-1.60
176.04%
-3.23
101.28%
3.81
217.95%
2.22
41.76%
11.24
407.26%
3.23
71.30%
2.43
24.79%
-10.76
543.30%
35.25
427.69%
free cash flow yield
0.01
-
-0.00
128.79%
-0.01
105.71%
0.00
157.32%
0.00
35.88%
0.02
592.32%
0.01
67.92%
0.00
53.95%
-0.01
583.98%
0.06
539.83%
graham net net
-15.79
-
-15.04
4.76%
0.03
100.20%
2.46
8,046.03%
54.36
2,106.32%
55.60
2.29%
20.80
62.59%
49.06
135.90%
43.78
10.76%
310.20
608.47%
graham number
81.10
-
96.67
19.20%
124.91
29.22%
243.75
95.14%
391.24
60.51%
386.12
1.31%
343.80
10.96%
351.03
2.10%
221.40
36.93%
485.12
119.12%
income quality
1.12
-
0.69
38.18%
0.50
28.23%
0.55
11.77%
0.52
5.65%
0.81
55.20%
0.73
9.52%
0.52
29.74%
0.23
55.39%
0.99
328.38%
intangibles to total assets
0.03
-
0.03
24.02%
0.00
85.27%
0.00
48.83%
0.00
26.92%
0.00
36.35%
0.00
5.13%
0.00
2.27%
0.03
1,226.05%
0.03
27.61%
interest coverage
4.39
-
5.64
28.45%
11.14
97.56%
40.97
267.87%
66.33
61.89%
44.32
33.18%
27.75
37.39%
56.93
105.15%
16.66
70.74%
60.44
262.81%
interest debt per share
17.26
-
20.74
20.15%
7.85
62.18%
13.64
73.82%
10.51
22.92%
21.85
107.85%
19.08
12.69%
16.07
15.78%
24.41
51.90%
9.93
59.34%
inventory turnover
1.52
-
1.29
15.44%
1.10
14.54%
1.99
80.77%
1.16
41.64%
0.87
24.78%
0.91
4.68%
0.76
16.67%
0.89
17.43%
0.84
5.59%
invested capital
0.33
-
0.37
11.30%
0.09
76.59%
0.13
55.04%
0.06
58.04%
0.11
96.39%
0.09
21.16%
0.07
21.09%
0.10
47.10%
0.03
66.24%
market cap
25.51B
-
69.85B
173.80%
70.34B
0.71%
147.95B
110.33%
136.78B
7.55%
104.11B
23.88%
91.98B
11.66%
150.38B
63.50%
137.92B
8.28%
102.85B
25.43%
net current asset value
-948.17M
-
-500.03M
47.26%
3.12B
723.46%
4.23B
35.72%
14.92B
252.54%
15.35B
2.92%
15.22B
0.82%
16.69B
9.61%
16.52B
1.02%
64.80B
292.34%
net debt to ebitda
1.19
-
1.34
12.19%
0.24
82.29%
0.27
15.80%
0.16
43.12%
0.39
151.67%
0.46
16.57%
0.38
17.80%
0.96
154.99%
0.03
96.52%
net income per share
6.43
-
8.13
26.39%
9.10
11.99%
27.89
206.40%
39.26
40.76%
34.98
10.90%
25.33
27.60%
24.20
4.44%
9.32
61.49%
39.18
320.39%
operating cash flow per share
9.02
-
5.60
37.94%
6.01
7.34%
19.85
230.44%
26.15
31.73%
36.31
38.87%
22.94
36.83%
16.40
28.48%
2.55
84.46%
46.51
1,724.38%
payables turnover
2.51
-
2.26
10.01%
153.84
6,705.59%
347
125.56%
106.02
69.45%
2.13
97.99%
2.00
6.19%
4.16
108.23%
4.21
1.30%
2.38
43.54%
receivables turnover
5.00
-
3.81
23.90%
3.04
20.10%
3.87
27.21%
3.01
22.20%
3.01
0.08%
3.59
-
2.84
20.96%
3.12
10.07%
research and ddevelopement to revenue
0.02
-
0.02
21.21%
0.01
13.01%
0.02
68.32%
0.02
5.00%
0.04
63.92%
0.03
4.51%
0.09
159.89%
0.09
6.57%
0.03
64.12%
return on tangible assets
0.09
-
0.10
13.96%
0.09
15.01%
0.21
145.87%
0.19
10.57%
0.15
20.18%
0.10
32.94%
0.09
8.39%
0.03
62.94%
0.13
282.81%
revenue per share
45.75
-
49.43
8.05%
65.99
33.50%
117.08
77.42%
121.63
3.88%
111.93
7.98%
103.76
7.30%
92.79
10.57%
104.43
12.54%
148.28
41.98%
roe
0.14
-
0.16
12.42%
0.12
24.88%
0.29
146.55%
0.23
23.10%
0.18
18.50%
0.12
33.88%
0.11
12.40%
0.04
62.73%
0.15
268.08%
roic
0.11
-
0.13
22.41%
0.12
5.49%
0.27
118.22%
0.21
22.31%
0.14
31.73%
0.10
33.21%
0.09
9.99%
0.04
54.73%
0.14
267.26%
sales general and administrative to revenue
0.04
-
0.03
19.10%
0.02
23.98%
0.02
16.92%
0.02
5.17%
0.02
41.12%
0.03
24.73%
0.03
7.50%
0.04
28.47%
0.04
8.04%
shareholders equity per share
45.44
-
51.09
12.42%
76.17
49.09%
94.66
24.28%
173.26
83.03%
189.41
9.32%
207.41
9.50%
226.26
9.09%
233.75
3.31%
266.96
14.21%
stock based compensation to revenue
0.01
-
0.01
29.98%
0.01
38.42%
0.01
47.03%
0.01
37.84%
0.01
2.28%
0.00
84.51%
tangible asset value
7.01B
-
8.05B
14.90%
12.94B
60.76%
16.48B
27.29%
30.64B
85.98%
34.82B
13.64%
37.76B
8.43%
41.14B
8.95%
41.31B
0.41%
89.50B
116.66%
tangible book value per share
43.87
-
48.62
10.82%
75.94
56.19%
94.57
24.53%
172.81
82.74%
189.04
9.39%
207.54
9.78%
225.85
8.82%
226.46
0.27%
490.21
116.47%
working capital
558.54M
-
692.26M
23.94%
3.39B
390.28%
4.61B
35.77%
15.39B
233.92%
16.18B
5.19%
16.40B
1.35%
18.12B
10.45%
17.87B
1.37%
23.17B
29.68%

All numbers in INR (except ratios and percentages)